chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case is linked to case 2021SA377054 (CLUSTER). This case involves two patient (unknown age and gender) who experienced dizzy (Dizziness) while receiving MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI]. The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV VACCINE (HPV VACCINE). On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [lot number not reported, and expiry date not provided] via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient experienced dizzy (Dizziness) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. It was reported "Rep reports that Nurse Practitioner has informed him of 3 patients who experienced adverse events when receiving MENQUADFI vaccine. She stated that 2 patients who received the MENQUADFI concomitantly with the HPV vaccine complained of dizziness. One additional patient, no concomitant vaccines mentioned, "almost fell on the floor". Description was vague, but sales rep states that fainting or almost fainting was implied". Details of laboratory data were not reported. It was not reported if the patient received any corrective treatment. At the time of report, the outcome of event was unknown. There will be no information available on batch number for this case. Based on information previously received, case classification and case validity in narrative has been amended.
101.3  Fever; Fatigue; weakness; Pain at the injection site; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient re-ceived second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263), via an unspecified route of administration, administered in left arm on 12Feb2021 at 10:00 (at the age of 74 years old) as a single dose for COVID-19 immunisation. Medical history included Asthma, COPD, allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Con-comitant medications included for-moterol fumarate, mometasone furoate (DULERA), lisinopril, atorvastatin, albuterol and vitamin D. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took historical vaccine on first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3248) in left arm on 25Jan2021 at 10:00 for COVID-19 immunisation. On 12Feb2021 at 20:00 the patient experienced 101.3 fever, fatigue, weakness and pain at the injection site. The patient did not receive any treatment for the events. The patient underwent lab tests and procedures which included body temperature 101.3 on 12Feb2021. The outcome of the events was recovering.
tearing in the left eye; Burning; Pain in the left eye; double vision; Pain; This is a spontaneous report from a contactable consumer or other non-Health Care Professional. A 56-years-old female patient received bnt162b2 , PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: FA7485 and Expiry date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 03Aug2021 10:00 at the age of 56-years-old as DOSE 1, SINGLE for covid-19 immunization. Medical history included familial Mediterranean fever, drug hypersensitivity, iodine allergy. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient received other medications of vaccination.The patient was not diagnosed with Covid 19 and has not been tested for Covid-19 Since the vaccination. Concomitant medication included colchicine taken for an unspecified indication, start and stop date were not reported.On 04Aug2021 03:00 the patient experienced tearing in the left eye, burning, pain in the left eye, double vision, pain. Patient was not revived any treatment. The outcome of events was recovering. No further in formation is expected.
Woke up with my upper lip swollen and I do have dermal filler in that lip; body aches/pains; flu; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 30Sep2021 (Lot number: 30155BA) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1), for COVID-19 immunization; Bnt162b2 (Dose:2), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 30Sep2021, outcome "unknown", described as "body aches/pains"; INFLUENZA (non-serious) with onset 30Sep2021, outcome "unknown", described as "flu"; LIP SWELLING (non-serious) with onset 02Oct2021, outcome "unknown", described as "Woke up with my upper lip swollen and I do have dermal filler in that lip".  Additional Context:Consumer stated, had a Pfizer booster on Friday night, all day, mean on Thursday night, all day yesterday had the body aches, 'flu', pains and everything (further not clarified) that had with the other two shots. However, got up at 3 o'clock this morning and upper lip (Voice breaking) icing it,did have dermal fillers in that lip, woke up with upper lip swollen and did had dermal filler in that lip, so of course googled it and that was a reaction to the other, Moderna, but couldn't find anything that was a reaction to the Pfizer. So went to the urgent care, they sent me to back to withheld where  got it and withheld said go back to urgent care and call Pfizer. So, had calling Pfizer, had  you heard this before, what was going on.
Patient got covid-19 after the first dose of the vaccine.; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Patient got covid-19 after the first dose of the vaccine.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient got covid-19 after the first dose of the vaccine.). At the time of the report, COVID-19 (Patient got covid-19 after the first dose of the vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
The MA gave the shot out of the vial that was opened on 11-14-22.  The vial had been open more than 12 hours and was kept in the fridge during that time.
Facial numbness; Puffiness; This is a spontaneous report from a contactable consumer . A 56-years-old female patient received the second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL0142 and expiry date was not provided), via an unspecified route of administration, administered in Arm Left on 04Jan2021 15:30 as single dose for COVID-19 immunisation. Medical history included Early menopause, hypothyroidism from Oct2020 still ongoing  and Pollen-Seasonal allergies, Sinus congestion. The patient previously took first dose of historical vaccine BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EH9899 and expiry date was not provided), via an unspecified route of administration, administered in Arm Left on 14Dec2020 15:30 as SINGLE DOSE for covid-19 immunisation and experienced Facial Numbness, swelling, flushed, Extreme fatigue 24 hrs after vaccine, multi joint pain, Also felt 'a little bit' of nausea, Funny- Brain fog. Concomitant medications included estrogens conjugated (PREMARIN) taken for premature menopause as 0.625mg Daily, levothyroxine sodium (SYNTHROID) taken for hypothyroidism as 50mcg daily in Am with water 30minutes prior to eating. Past drug event included Codiene(CODEINE) which causes nausea and cetirizine hydrochloride(ZYRTEC) for seasonal allergies. patient was given antihistamines; Zyrtec 1/2 tablet daily for seasonal allergies.On Jan2021, the patient experienced facial numbness and puffiness. Treatment received for the events reported. Outcome of the events was unknown.
gotten the pneumonia three times as year; flu; Initial information was received on 29-Nov-2020 regarding an unsolicited valid serious case from a consumer (patient) via social media (Facebook).  This case involves a patient (unknown demographics) who experienced pneumonia three times as year (pneumonia) and flu (influenza), while the patient received vaccine INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer and PNEUMOCOCCAL VACCINE not produced by Sanofi Pasteur (lot number and expiry date not reported for both suspect) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient had pneumonia up to 3 times as year (serious) and always got flu (influenza)(non-serious) (unknown latency) after the administration of INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE. Pneumonia was assessed as medically significant  It was reported that, the patient did not had these vaccine for two years and did not experienced these events.   Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the events.  Information on the batch number was requested.; Sender's Comments: This was a poorly documented social media case received from Facebook involves a patient (unknown demography) who had influenza and pneumonia after vaccination with INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE. Time to onset is unknown. Additional information regarding patient's medical history, health condition at time of vaccination and laboratory tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the individual vaccine cannot be assessed.
Information has been received from a  physician concerning a 23 year old female with a history of endometriosis who on 24-JUL-2008 was vaccinated with the first dose of GARDASIL. Concomitant therapy included ALLEGRA-D and YAZ. The patient developed pharyngitis followed by a rash after receiving her first dose of GARDASIL. The patient was treated by her family physician (not this physician) with steroids. After this treatment the patient experienced weight gain, syncope and possible seizure. The patient was evaluated in an emergency room for syncope and possible seizure. A complete blood cell count (CBC) and blood chemistry panel were performed and the results were within normal limits. At the time of reporting the patient continued to experience some lightheadedness and her weight was still greater than it was prior to receiving GARDASIL. The pharyngitis and rash had been resolved. Upon internal review possible seizure was considered to be an other important medical event. Additional information has been requested.
I had severe headaches and very sharp sight on the first day. The next day I experienced a strange leg numbness in the middle of the night. A week later as I was traveling I had a very bad allergic reaction that required me to call 911, as the throat swallowed. I am still experiencing leg pain when I walk. Sometimes the face feels tight also and I?m not sure this is something from the vaccine.
Initial report received from a healthcare professional on 30 May 2012. A patient, gender, medical history and concomitant medication were not reported, had received a dose of FLUZONE ID (As per triage suspect product perhaps should be FLUZONE) on an unspecified date (lot number, site of vaccination were not reported). It was reported that, the patient presented fever, headache, aches, swelling and redness of whole deltoid and running nose. The lab details and corrective treatment details were not reported. The outcome was not reported. Documents held by sender: none.
A 91 year old male pt was treated with Oncotice for an unk indication. Reportedly, after one instillation he developed a urinary tract infection. For treatment sulfamethoxazole trimethoprim was prescribed.
Patient reports having a red, inflamed, "bump" around the area of injection. It was recommended that the patient monitor the status of the area, if worsens to see medical attention. In the meantime treat with cold compress and pain medication such as ibuprofen.
02/19/22 presents to ED for "Increased lower extremity edema/erythema". PMHx of "alcohol abuse, bipolar disorder, cirrhosis, COPD, diabetes mellitus, dyslipidemia, esophageal varices, GERD, hepatic encephalopathy, hepatitis C, dyslipidemia, hypertension, obesity, OSA, hypercarbic respiratory failure"
Saturday noc had a grape sized red lump;feeling tired;non-tender, felt firm;less on 27SEP;better today;
101.2  Fever, Muscle aches and arm hurting, bulge at injection site and hardness there, headache, nauseated, no appetite gone by day 3, took two tylonal and drank a lot of water
Very tired; sluggish; groggy; Left arm is very sore at site of vaccination; body in general is relatively achy.; Location of injection for vaccine received same date: Flu Shot - Left arm; Location of injection for vaccine received same date: Flu Shot - Left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 24-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Nov2022 at 15:45 as dose 4 (booster), single (Lot number: GH9702) at the age of 24 years intramuscular, in left arm for covid-19 immunisation; influenza vaccine (FLU [INFLUENZA VACCINE]), on 17Nov2022 as dose number unknown, single (Batch/Lot number: unknown), in left arm for immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ALLEGRA [FEXOFENADINE HYDROCHLORIDE]; SYMBICORT. Vaccination history included: Covid-19 vaccine (DOSE 1, Unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (DOSE 3 (Booster), Unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (DOSE 2, Unknown manufacturer), for Covid-19 immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 17Nov2022, outcome "unknown" and all described as "Location of injection for vaccine received same date: Flu Shot - Left arm"; VACCINATION SITE PAIN (non-serious) with onset 18Nov2022, outcome "recovering", described as "Left arm is very sore at site of vaccination"; FATIGUE (non-serious) with onset 18Nov2022, outcome "recovering", described as "Very tired"; PAIN (non-serious) with onset 18Nov2022, outcome "recovering", described as "body in general is relatively achy."; SOMNOLENCE (non-serious) with onset 18Nov2022, outcome "recovering", described as "groggy"; SLUGGISHNESS (non-serious) with onset 18Nov2022, outcome "recovering", described as "sluggish". Therapeutic measures were not taken as a result of fatigue, sluggishness, somnolence, vaccination site pain, pain.  Additional information: No other vaccine in four weeks. Patient was very tired, sluggish, and groggy the day after the vaccine. Left arm was very sore at site of vaccination and body in general was relatively achy. No Covid prior vaccination. Patient was not tested for Covid post vaccination. No known allergies.
High fever of 103.3 which dropped to 101.1. Lasted 24 hours. Tylenol dropped it to 99, then it would rise again.  Pounding headache. Lasted 24 hours. Tylenol helped.
Initial information was received on 16 December 2008 from a health care professional.  A 38 year old female patient with no known allergies received a first time dose of ADACEL (lot number C2965AA) in the left deltoid intramuscularly on 12 December 2008.  On 13 December 2008 the patient reported pain and swelling at the injection site.  The patient was seen by a physician on 15 December 2008 and the site was inflamed and red 3"x3".  The patient did not have a fever or chills.  The patient's recovery status was unknown at the time of the report.  No further information was reported.  Follow-up information received 09 February 2009 from a health care professional who reported that the patient recovered from the event (previously reported as unknown).  No additional information was provided.  List of Documents held by Sender:  None.
Approx <5 min s/p vaccine administration, patient felt lightheaded with near-syncope, complaint of headache and diaphoretic.  Vitals signs were obtained.  Patient's VSS.  Ice packs provided.   Patient observed and re-checked within 10 minutes.  Well appearing.
Beginning on Friday, 6/25/21, began to feel like lungs were 'heavy,' and that normal oxygenation wasn't occurring even with a deep breath. I had attended a memorial visitation the evening of June 6/22/21 at the Funeral Home in town and it was the first time post-vaccination that I attended a gathering (small) without a mask; others were also unmasked. I suspect the issue emanates from this interaction. As of this writing, I feel that I am not getting a full, deep and fully-oxygenated breath when I breath. This morning, around 1AM EST, I had slight wheezing on my inhales, which seems to have subsided after I walked the dog down the block and back (slowly). No other discernable Covid-related symptoms to report.
Pt began having rash on leg administered. Rash spreading. Pt mom told to give BENADRYL & TYLENOL.
Sharp pain on left arm wrist; Tenosynovitis on left wrist; This non-serious case was reported by a physician via call center representative and described the occurrence of wrist pain in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In FEB-2023, the patient received the 1st dose of Shingrix (left arm). On an unknown date, 2 hrs after receiving Shingrix, the patient experienced wrist pain (Verbatim: Sharp pain on left arm wrist) and tenosynovitis (Verbatim: Tenosynovitis on left wrist). The outcome of the wrist pain and tenosynovitis were unknown.   It was unknown if the reporter considered the wrist pain and tenosynovitis to be related to Shingrix.     It was unknown if the company considered the wrist pain and tenosynovitis to be related to Shingrix.   Additional Information: GSK Receipt Date: 20-MAR-2023 The patient self-reported this case.  The reporter reported that tenosynovitis after the administration of Shingrix, the administration of the 1st dose was around February 2023. The patient did not want to go for the 2nd shot, she was a little bit concern about it. The patient said the same site on the shot, within 2 to 3 hours of the shot, she started having sharp pain on the left arm wrist and progressed to tenosynovitis, it was just very peculiar as the patient was right-handed person. The reporter was consented to follow up.
Vaccine given 2 days after expiration date 6-23-15-spoke with mom. Daughter did not have any reactions.
MD reported that a pt devel urticaria following vax w/MMR; No further details were provided;
Narrative: 89 year old male who was at nursing facility under facility contract passed away on january 13, 2022. Pt had the following problem list: PROBLEM LAST MOD PROVIDER End-stage renal disease 08/03/2018 (ICD-10-CM N18.6) Hyperparathyroidism due to renal insufficiency 08/03/2018 (ICD-10-CM N25.81) Legal blindness (ICD-10-CM H54.8) 08/24/2016 Diastolic heart failure 04/25/2016 (ICD-10-cm I50.32) Chronic kidney disease stage 3 03/10/2016 (ICD-10-CM N18.3) Delirium (ICD-9-CM 293.0) 08/12/2015 Hyperpotassemia (ICD-9-CM 276.7) 05/08/2014 Other B-complex deficiencies (ICD-9-CM 266.2) 05/08/2014 Inguinal hernia, without mention of obstruction 04/08/2004 or gangrene (ICD-9-CM 550.90) Chronic airway obstruction. Not Elsewhere 06/11/2013 Classified (ICD-9-CM 496.) (ICD-10-CM Z95.0); Presence of cardiac pacemaker 02/29/2016 not known (ICD-9-CM 209.41); Benign Carcinoid Tumor of the 07/17/2012 Duodenum (ICD-9-CM 209.41) (ICD-9-CM 588.81); Secondary Hyperparathyroidism 07/12/2012 (of Renal Origin) (ICD-9-cm 588.81) (ICD-9-CM 428.0); (ICD-9-CM 428.0) 02/16/2012 (ICD-9-CM 276.8); Hypokalemia (ICD-9-CM 276.8) 02/16/2012 (ICD-9 416.8); Pulmonary Hypertension 08/23/2010 (ICD-9-CM 416.8) (ICD-9-CM V71.89); Observation for other 04/20/2010 specified suspected Condition (ICD-9-V71.89) Coronary Artery Disease 02/01/2016 (ICD-10-CM Z95.0), Onset 04/00/2010 Non-obstructive, single-vessel (30% LAD) Chronic Kidney Disease, Stage III (Moderate) 04/19/2010 (ICD-9-CM 585.3), Onset 04/00/2010 (ICD-9-CM 427.32); Atrial Flutter (ICD-9-CM 10/20/2009 427.32) (ICD-9-CM 729.81); Swelling of limb (ICD-9-CM 06/16/2009 729.81) (ICD-9-CM 250.00); Diabetes Mellitus Type II or 06/19/2008 unspecified (ICD-9-CM 250.00) (ICD-9-CM 272.4); Hyperlipidemia (ICD-9-CM 06/19/2008 272.4) (ICD-9-CM 727.05); Other tenosynovitis of hand 03/03/2008 and wrist (ICD-9-CM 727.05) (ICD-9-CM 719.00); Joint Effusion (ICD-9-CM 12/31/2007 719.00) (ICD-9-CM 719.47); Pain in joint involving ankle 08/11/2007 and foot (ICD-9-CM 719.47) (ICD-9-CM 782.3); Edema (ICD-9-CM 782.3) 04/29/2007 (ICD-9-CM 426.6); Other heart block (ICD-9-CM 04/20/2007 426.6) (ICD-9-CM 389.10); SENSORNEUR HEAR LOSS 03/07/2005 Cardiac dysrhythmia (ICD-9-CM 427.9) 05/17/2000 Essential Hypertension (ICD-10-CM 04/25/2016 I10.) Pt had received covid vaccines on 4/1/21 & 4/29/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & death & date of vaccine administrations.
Large (quarter-size or larger) red hives began appearing on thighs. Each would only last an hour or two, but as it would fade, another would appear elsewhere on legs. They then spread to lower legs and face and finally, the next morning, to arms. At the same time, fever was between 100.5 and 101.8.
Arm is sore; mild aches all over body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Mar2021 12:45 (Lot number: EP6955) at the age of 44 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ATORVASTATIN. Vaccination history included: Covid-19 vaccine (product=COVID 19, brand=Pfizer,, Lot number=EL3248,, Lot unknown=False,, Administration date=03Mar2021,, Vaccine location=Left arm,, Dose number=1), administration date: 03Mar2021, for Covid-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 25Mar2021, outcome "not recovered", described as "Arm is sore"; PAIN (non-serious) with onset 25Mar2021, outcome "not recovered", described as "mild aches all over body". Therapeutic measures were not taken as a result of pain in extremity, pain. Additional information: Patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received atorvastatin within 2 weeks of vaccination. No follow-up attempts are possible. No further information is expected.